Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
Clario, a leading provider of endpoint data solutions to the clinical trials industry, today announced that its artificial intelligence (AI) management ...
The Print on MSN
Govt planning regulatory sandboxes for pharma sector to fast-track approvals & drug development
On the sidelines of the Bio Asia event in Hyderabad, BIRAC MD Jitendra Kumar says biotechnology department is planning the ...
Stocktwits on MSN
FDA commissioner raises concerns about US pharma lagging behind China in drug development
Makary urged the Trump administration to partner with the pharmaceutical industry. ・The senior official is of the opinion that there exists multiple bottlenecks that have caused the U.S. to lag behind ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Patients Implanted; Enrollment Completion Anticipated by End of March White Bear Lake, Minnesota–(Newsfile Corp. – February 17, 2026) – Envoy Medical® Inc. (NASDAQ: COCH) (“Envoy Medical” ...
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
Deupirfenidone, a potential new treatment for idiopathic pulmonary fibrosis, is set to be tested in a phase 3 trial this year after a successful phase 2b trial and meeting with the FDA, according to a ...
Thank you for standing by, and welcome to the Krystal Biotech 4Q 2025 Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to hand the ...
AI can transform healthcare, but risks remain: liability, bias, blurred “wellness vs medicine,” and jagged model errors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results